Glycoprotein VI deficiency
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion.
|
12738669 |
2003 |
Glycoprotein VI deficiency
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families.
|
23815599 |
2013 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.
|
12515812 |
2003 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily.
|
10961879 |
2000 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We investigated whether polymorphic variation at the GP VI locus confers an increased risk of myocardial infarction (MI).
|
11571236 |
2001 |
Myocardial Infarction
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Platelet GPVI surface expression is enhanced following acute ischemic events like myocardial infarction and cerebral stroke, serves as an imminent diagnostic tool independent of markers of tissue necrosis, and is associated with poor prognosis.
|
27753514 |
2017 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A significant association between GP VI 13254C allele carriers and premature MI was found (p=0.025).
|
19786296 |
2010 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction.
|
10468872 |
1999 |
Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our preliminary data suggests that platelet collagen receptor density, when measured directly, may be related to prior myocardial infarction.
|
15874887 |
2005 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The combined ThrThr/TT haplotype of GPIbalpha as well as the AA genotype of GPIV seem to decrease the risk of fatal MI among men during early middle-age.
|
17619827 |
2008 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We studied the association of the GPVI T13254C with fatal myocardial infarction (MI) and coronary artery disease among the 300 men of the Helsinki Sudden Death Study (HSDS).
|
15306180 |
2004 |
Myocardial Infarction
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Increased GPVI levels are associated with poor clinical outcome and are an early indicator for imminent myocardial infarction in patients with chest pain.
|
24553806 |
2014 |
Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Also, treatment of mice undergoing experimental myocardial infarction with αCD133-GPVI-labeled progenitor cells reduces infarction size and preserves myocardial function.
|
22448969 |
2012 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The impact of platelet collagen receptor polymorphisms in the pathogenesis of myocardial infarction at young age remains unknown.
|
22627583 |
2012 |
Stiff-Person Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
The aim of our study was to evaluate GP6 gene in patients with sticky platelet syndrome (SPS) and fetal loss.
|
30278775 |
2018 |
Stiff-Person Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
The objectives of the present study were to assess the genetic variability of the GP6 gene in patients with platelet hyperaggregability phenotype, known as sticky platelet syndrome (SPS) manifesting as deep vein thrombosis (DVT), and/or pulmonary embolism, and in controls; and to evaluate its role in the pathogenesis of venous thromboembolism (VTE) in SPS.
|
22821001 |
2012 |
Stiff-Person Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
The aim of the study was to examine the genetic linkage of this selected risk haplotype with single nucleotide variations (SNVs) in the coding sequence of the GP6 gene in order to identify possible functional SNVs in association with SPS and fetal loss.
|
28041267 |
2018 |